Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    "Mycobacterium Malmoense"
Show Display Options
Rank Status Study
1 Completed Clarithromycin v Ciprofloxacin Added to Rifampicin + Ethambutol, for Opportunist Mycobacterial Pulmonary Disease
Condition: Pulmonary Diseases
Interventions: Drug: Addition of clarithromycin to rifampicin and ethambutol;   Drug: Addition of Ciprofloxacin to rifampicin and ethambutol;   Biological: Vaccination with M.vaccae

Study has passed its completion date and status has not been verified in more than two years.